Ensemble Discovery Corp.
This article was originally published in Start Up
Executive Summary
Ensemble Discovery Corp. is developing a breakthrough system for assembling and discovering new molecular entities. The company's proprietary technology, DNA-Programmed Chemistry, can quickly synthesize molecules that are intractable to traditional synthesis techniques as well as identify and purify novel molecules with desired properties.
You may also be interested in...
The A-List: 2004's Trend-Shaping Series A Financings
Analyzing the venture financings closed by 2004's new crop of biotech, diagnostics, and medical device start-ups reveals today's trends that may shape tomorrow's health care industry. Here we point out eleven 2004 Series A financings that identify and illustrate what's hot.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.